Another study reported that ERK1/2 and EGFR-PI3K-Akt pathways seem to be involved in cellular survival after PDT and EGFR inhibitors and PDT act synergistically to reduce malignant tumors effectively [52]. This evidence concerns the gene EGFR and cancer.